OWINGS MILLS, Md., Oct 19, 2010 /PRNewswire via COMTEX News Network/ -- Medifast, Inc. (NYSE: MED) a leading provider of clinically proven portion-controlled weight-loss programs, will announce results for the third quarter ended September 30, 2010 on Thursday, November 4, 2010, after market close. The Company will host a conference call to discuss these results with additional comments and details.
The conference call is scheduled to begin at 4:30 p.m. ET on November 4, 2010. The call will be broadcast live over the Internet hosted at the Investor Relations section of Medifast's website at www.choosemedifast.com, and will be archived online through November 18, 2010. In addition, listeners may dial (877) 407-4018 in North America, and international listeners may dial (201) 689-8471. Participants from the Company will be Michael S. McDevitt, Chief Executive Officer, and Brendan Connors, Chief Financial Officer.
A telephonic playback will be available from 7:30 p.m. ET, November 4, 2010, through November 18, 2010. Participants can dial (877) 870-5176 to hear the playback and enter passcode 359364.
Medifast, Inc. (NYSE: MED) is a leading provider of clinically proven, portion-controlled weight-loss programs. Medifast has been recommended by over 20,000 doctors and used by over one million clients since 1980. The Company is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major universities. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape for Life personal coaching division, 3) medically supervised Medifast Weight Control Centers, and 4) a national network of physicians. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, please visit http://www.choosemedifast.com.
Investor Contact: Brendan Connors Chief Financial Officer email@example.com ICR, Inc. Katie Turner John Mills (646) 277-1228
SOURCE Medifast, Inc.
Copyright (C) 2010 PR Newswire. All rights reserved